Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Neutropenia Market (2023-2028) by Treatment, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Neutropenia Market is estimated to be USD 4.26 Bn in 2023 and is expected to reach USD 5.77 Bn by 2028, growing at a CAGR of 6.2%.
Neutropenia is a medical disorder characterized by an unusually low quantity of neutrophils, a type of white blood cell that plays an important part in the immunological response of the body. It can weaken the immune system, making people more vulnerable to infections, and it can be caused by a variety of factors, including particular drugs or medical conditions.
The rising prevalence of leukemia, a kind of blood cancer frequently associated with neutropenia, is a major market driver for neutropenia. As the number of leukemia patients increases, so does the demand for treatments that target low neutrophil numbers. This tendency has generated an emphasis on developing medicines that increase neutrophil production, hence improving patient outcomes and quality of life.
Increased research and development initiatives have resulted from a better understanding of neutropenia's influence on patients. To fight neutropenia more effectively, pharmaceutical companies are investing in new drug research and treatment options. The launch of new medications with enhanced efficacy and safety profiles improves the market outlook overall.
The market for cancer supportive treatments, especially those for neutropenia management, has seen a trend away from more expensive branded medications and towards less priced biosimilars. This transformation is being driven by cost-effectiveness and increasing access to high-quality treatment choices, which will broaden the reach of the neutropenia market and benefit patients worldwide.
The emergence of a strong pharmacological pipeline primarily addressing neutropenia treatment creates a market potential. With multiple promising medications in various phases of research, this signifies a substantial advancement in neutropenia management. When these pharmaceuticals hit the market, they will be able to address unmet medical needs, attract investment, and enhance patient outcomes.
However, the market for neutropenia is restricted by high treatment costs. The costs of treating neutropenia, including drugs and supportive care, can be prohibitively expensive for individuals and healthcare systems, limiting access and uptake of these therapies.
The neutropenia market faces the challenge of managing tight laws and regulations for product approvals. Long and complicated approval processes imposed by regulatory bodies can cause delays in drug development and market access, providing challenges for pharmaceutical companies wanting to deliver new neutropenia therapies.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Neutropenia Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Neutropenia Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, The analyst has devised suitable strategies for market growth.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Neutropenia Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
- Excel data sheet for the market size will also be provided with the report.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
- The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
- The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 199 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $4.26 Billion |
| Forecasted Market Value (USD) by 2028 | $5.77 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Rise in Prevalence of Leukemia
- Surge in R&D Efforts and Development of New Drugs
- Fundamental Shift from Branded Drugs to Biosimilars in Cancer Supportive Treatment
Restraints
- High Cost of the Treatment of Neutropenia
Opportunities
- Robust Drug Pipeline for Neutropenia Treatment
Challenges
- Stringent Rules and Regulations for Product Approvals
Companies Mentioned
- Amgen
- Baxter International Inc.
- BeyondSpring Pharmaceuticals
- Biogen Inc.
- Cantargia
- Coherus Biosciences
- Dong-A ST
- Enzychem Lifesciences
- Gilead Sciences, Inc.
- Kyowa Kirin
- Merck & Co., Inc.
- Myelo Therapeutics
- Mylan Institutional (Fulphila)
- Novartis Pharmaceuticals
- Partner Therapeutics
- Pfizer
- Sandoz (Novartis)
- Sanofi S.A.
- Spectrum Pharmaceuticals
- Teva Pharmaceutical
Market Segmentation
- The Global Neutropenia Market is segmented based on Treatment, Distribution Channel, and Geography.
- By Treatment, the Global Neutropenia Market is classified into Colony-Stimulating Factors (CSFs), Antibiotics, and Antivirals.
- Colony-Stimulating Factors (CSFs) hold a larger market share. CSFs are especially designed to increase white blood cell production, so addressing the underlying cause of neutropenia, making them a primary and more targeted therapy option for treating this illness.
- By Distribution Channel, the Global Neutropenia Market is classified into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
- Hospital Pharmacies hold a significant market share. Due to the specialized nature of these treatments and the necessity for close monitoring, healthcare facilities play an important role in dispensing and managing neutropenia drugs.
- By Geography, the Global Neutropenia Market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.
- The Americas hold a larger market share. This was due to parameters such as the region's increased prevalence of neutropenia-related illnesses, improved healthcare infrastructure, and greater availability to advanced medical treatments.
For more information about this report visit https://www.researchandmarkets.com/r/k25gby
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
